Compounding Of Commercial Products Should Be Emergency-Only - PhRMA
Executive Summary
Pharmacy compounding of commercially available pharmaceutical products should be restricted to "emergency situation[s] as a one-time event," the Pharmaceutical Research & Manufacturers of America said in April 24 comments to FDA.